Literature DB >> 34648408

Use of modern contraceptives in Lagos Nigeria during the COVID-19 pandemic.

Kikelomo Ololade Wright1,2, Onipede Wusu3, Modupe Akinyinka1, Bisola Adebayo1, Funmilade Adepoju2, Khadija Bashir2, Aderinsola Anifowose2, Folakemi Ezenwanne4, Aduragbemi Oluwabusayo Banke-Thomas5.   

Abstract

We estimated modern contraceptive prevalence rate (mCPR) and examined predictors of modern contraceptives utilization amongst 1,445 sampled reproductive age women in Lagos (Nigeria's epicenter) during the devastating COVID-19 pandemic. Estimated mCPR was 30.8%. Women aged 20-29 years were 50% (95%CI:0.37-0.71) less likely to use modern contraceptives during the pandemic than those 30-39 years. Married and divorced women were about three (95%CI:1.37-5.25) and over three (95%CI:1.32-7.79) times more likely to use modern contraceptives compared to single women. Though mCPR has not reduced, sustained contraceptive needs assessment of sometimes obscure sub-populations is required, especially if outbreaks like COVID-19 become our 'new normal'.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34648408     DOI: 10.1080/07399332.2021.1982946

Source DB:  PubMed          Journal:  Health Care Women Int        ISSN: 0739-9332


  1 in total

Review 1.  Looking ahead in the COVID-19 pandemic: emerging lessons learned for sexual and reproductive health services in low- and middle-income countries.

Authors:  Aduragbemi Banke-Thomas; Sanni Yaya
Journal:  Reprod Health       Date:  2021-12-14       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.